Invokana Injury side effects lawsuits on the rise. As the number of patients afflicted with diabetes continues to rise in the United States, so do the risks of serious Invokana Injury side effects from the popular diabetic medication.
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs.
Invokana Injury side effects claims now over 1,000
More than 1,000 Invokana injury side effects lawsuits are filed in the federal multidistrict litigation (MDL) set up for patients who have been victimized by lower limb amputations, diabetic ketoacidosis, kidney failure and other catastrophic injuries after use of the black boxed diabetes drug.
The Invokana cases involve three different injury categories, kidney failure, diabetic ketoacidosis, and allegations that Invokana increases the risk of amputations.
Kidney Failure allegations in recent lawsuit
Recently, a product liability lawsuit was filed against Johnson & Johnson’s Janssen Pharmaceuticals unit over a failure to warn about the risk of kidney failure from Invokana. According to the allegations, this lack of warning makes the infamous diabetes drug unreasonably dangerous for patients.
Jimmie Fielder filed suit in the U.S. District Court for the District of New Jersey with the claim that he would not have developed kidney failure if the manufacturers of Invokana had provided adequate warnings for diabetic patients and doctors.
Invokana Federal Multidistrict Litigation
Fielder’s case was filed in the U.S. District Court for the District of New Jersey, where more than nearly 1,000 other Invokana lawsuits are currently centralized and consolidated for coordinated pretrial proceedings, as part of a federal multidistrict litigation (MDL) before U.S. District Judge Brian Martinotti.
What is Invokana?
Invokana (canagliflozin) was approved for sale in March 2013, as the first member of a new class of diabetes drugs, known as sodium-glucose cotransporter 2 (SGLT2) inhibitors.
Similar SGLT2 drugs include Invokamet, Jardiance, Farxiga, Xigduo, and Invokana has the largest market share.
FDA Warnings over Invokana Side Effects
Since Invokana’s release, there have been many reports of catastrophic health complications from patients taking the type 2 diabetic medication. The FDA has ordered many warning label updates over the past several years.
In December 2015, the FDA ordered Johnson & Johnson to add new diabetic ketoacidosis warnings to Invokana, finding that the drug increases the risk of this dangerous medical condition.
In June 2016, the FDA ordered new label warnings about Invokana and kidney risks, finding that the drug increases the risk of acute kidney failure.
In May 2017, the FDA ordered new label warnings about Invokana and the increased risk of leg and foot amputations.
If you or someone you know developed Invokana Ketoacidosis, leg, foot, toes amputations or kidney failure by taking Invokana for the treatment of their type 2 diabetes, please call us for further information at 888-210-9693. Dr. Shezad Malik Law Firm based in Dallas, Texas is investigating Invokana Wrongful death, Invokana Ketoacidosis, leg amputations, and kidney failure cases nationwide from folks taking Invokana for the treatment of their type 2 diabetes.
Read more about Invokana side effects here